Quantcast Jay La Forest's Pharmacy News
Jay La Forest's Pharmacy News By
Pharmacy News - The Products And Services That Drive It Forward.
Jay La Forest's Pharmacy News >> MEDICAL October 24, 2014 members login here
>>  MEDICAL
Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014
BusinessWeek - 4 Hours ago
ATLANTA, Oct. 24, 2014 /PRNewswire/ -- According to a survey by KLAS, an independent research firm, Elekta's (EKTA-B.ST) MOSAIQ™ Oncology Information System earned the number one ranking in the medical
Elekta publ : MOSAIQ oncology information system ranks number one in KLAS Oncology 4 Traders
Elekta’s MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 Noodls
all 3 news articles >>      Add Comment

Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke
Reuters - 4 Hours ago
Findings Have Important Implications in the Treatment of Central Nervous System Diseases and Injury PR Newswire ROCKVILLE, Md., Oct. 24, 2014 ROCKVILLE, Md. , Oct. 24, 2014 /PRNewswire/ --  RegeneRx
     Add Comment

Two Alaska Radiation Oncology Centers Awarded Ambulatory Health Care Accreditation
BusinessWeek - 5 Hours ago
NASHVILLE, Tenn., Oct. 24, 2014 /PRNewswire/ -- RBS Evolution, owner and operator of cancer centers in rural, underserved areas, announced today that two of the company's radiation oncology centers, Peninsula
     Add Comment

New Colombia Resources Inc Subsidiary, Sannabis, Produces First Batch of Medical
Reuters - 4 Hours ago
Sannabis is producing a "Made in Colombia" topical cannabis medical product for worldwide distribution through infomercials. PR Newswire BOGOTA, Colombia, Oct. 24, 2014 BOGOTA, Colombia , Oct.
     Add Comment

Hearing the Ovarian Cancer Whisper Awards $125000 for Ovarian Cancer Research
BioPortfolio - 4 Hours ago
PALM BEACH, Fla. , Oct. 24, 2014 /PRNewswire/ --  H.O.W. ( Hearing the Ovarian Cancer Whisper) is pleased to announce that it has awarded $125,000 in total fellowship and grant monies for research in
Hearing the Ovarian Cancer Whisper Awards $125,000 for Ovarian Cancer Research KMEG 14
all 1 news articles >>      Add Comment

AstraZeneca cancer drug pipeline gets boost from European green light
Yahoo! Finance UK and Ireland - 5 Hours ago
AstraZeneca's (AZN.L) cancer drug pipeline received a boost on Friday, as European regulators recommended approval of an experimental medicine against ovarian cancer. The green light from the European
AstraZeneca cancer drug pipeline gets boost from European green light (Reuters) West Australian
UPDATE 1-AstraZeneca cancer drug pipeline gets boost from European green light Reuters UK
all 3 news articles >>      Add Comment

Europe backs continued use of Ariad Pharma's leukemia drug
CNBC - 5 Hours ago
Oct 24 (Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug Iclusig in its already approved indications to treat certain kinds of leukemia. However,
EU regulator backs continued use of Ariad Pharma's leukemia drug Reuters UK
Europe backs continued use of Ariad Pharma's leukaemia drug Reuters
all 2 news articles >>      Add Comment

UPDATE 1-EU regulator backs continued use of Ariad Pharma's leukaemia drug
Reuters UK - 4 Hours ago
(Adds details, background, shares) Oct 24 (Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug, Iclusig, in its already approved indications to treat
EU regulator backs continued use of Ariad Pharma's leukemia drug Reuters
UPDATE 1-EU regulator backs continued use of Ariad Pharma's leukemia drug CNBC
all 3 news articles >>      Add Comment

New Gene Linked To Blindness And Parkinson's Disease
Pettinga Financial Advisors - 5 Hours ago
Gene linked to blindness and Parkinson's disease opens venues for new treatments of aging-related disorders. Durham, NC - October 24, 2014 - (iNewswire) The retinal pigment epithelium (RPE) is a tissue,
     Add Comment

XTANDI™ (Enzalutamide) Capsules Receive Positive CHMP Opinion for the Treatment
BusinessWeek - 4 Hours ago
For chemotherapy-naïve patients, enzalutamide demonstrated a significant impact on overall survival compared to placebo Enzalutamide reduced the risk of death by 29% versus placebo Enzalutamide significantly
XTANDI (Enzalutamide) Capsules Receive Positive CHMP Opinion for the Treatment of FinanzNachrichten.de
all 1 news articles >>      Add Comment

BRIEF-Eckert & Ziegler to be European development partner for drug against pancreatic
Reuters - 5 Hours ago
Oct 24 (Reuters) - Eckert & Ziegler Strahlen Und Medizintechnik AG : * Says to be European development partner for promising drug against pancreatic cancer * Says drug to enter phase III clinical
Eckert & Ziegler Awarded Contract to Produce New Type of Medicine to Fight Pancreatic One News Page United Kingdom
all 1 news articles >>      Add Comment

AstraZeneca Ovarian-Cancer Drug Wins EU Agency’s Backing
Bloomberg - 5 Hours ago
AstraZeneca Plc (AZN) won backing from a European Union regulator for an ovarian-cancer drug, one of the experimental medicines the company cited as a reason for fending off Pfizer Inc.’s $117 billion
     Add Comment

Family blames dialysis for MERS victim’s death
Arab News - 15 Hours ago
The family of a 56-year-old victim of the MERS coronavirus has called for an investigation into his death. Members of the family suspect that the 56-year-old deceased, Hasen Al-Nufaiei from Taif, may
     Add Comment

Uber's one-shot deal: Flu vaccine at your doorstep
USA Today - 16 Hours ago
CAMBRIDGE, Mass. — The Uber driver had just turned on his cellphone when the call came in. Someone five minutes away wanted a flu shot. The SUV limo carried nurse Kate Dicker to the address, and she gathered
     Add Comment

MediciGlobal Supports TauRx Sponsorship of "Meet the Experts" Event at International
KPHO Phoenix - 16 Hours ago
SOURCE MediciGlobal TauRx Chairman Prof. Claude Wischik brings a clinical trial opportunity directly to caregivers and patients at breakfast event PHILADELPHIA The breakfast event, featuring leading
MediciGlobal Supports TauRx Sponsorship of "Meet the Experts" Event at Finwin
all 1 news articles >>      Add Comment

FDA Extends Review Date for NPS Pharma HRT
American Journal of Public Health - 4 Hours ago
Reuters Health Information October 24, 2014 (Reuters) - NPS Pharmaceuticals Inc said the U.S. Food and Drug Administration had extended the review date for its hormone replacement therapy by three
     Add Comment

Short TB Therapies Fail in Larger, Longer Trials
General Medicine eJournal - 4 Hours ago
Shorter regimens for the treatment of tuberculosis (TB) are not as good as standard 6-month therapy, according to results of three phase 3 trials published in the October 23 issue of the New England Journal
     Add Comment

Current Scale-up of Aid Unlikely to Contain Ebola in Liberia
General Medicine eJournal - 4 Hours ago
Mathematical modeling suggests that current international scale-up plans will not be enough to control the Ebola epidemic in Montserrado, Liberia, which is the focal point of the epidemic in West Africa.
     Add Comment

Implanted Ring Aims to Replace Reading Glasses
General Medicine eJournal - 4 Hours ago
A corneal implant targeted to people in their mid-40s who see well at a distance could soon replace the drugstore reading glasses they rely on to read texts and menus. As people age, their lenses grow
     Add Comment

AstraZeneca ovarian cancer drug wins European green light
Yahoo! News UK and Ireland - 5 Hours ago
AstraZeneca's cancer drug pipeline received a boost on Friday as European regulators recommended approval of an experimental medicine against ovarian cancer. The green light from the European Medicines
     Add Comment

Factors associated with nonadherence to diet and physical activity among nepalese
7thSpace - 4 Hours ago
Nonadherence to diet and physical activity is a major problem in the management of diabetes mellitus and its complications. This study was undertaken to measure the factors associated with nonadherence
     Add Comment

Cone beam computed tomography and periapical lesions: a systematic review analysing
International Endodontic Journal - 3 Hours ago
Abstract Aim To evaluate using a systematic review approach the diagnostic efficacy of CBCT for periapical lesions, focusing on the evidence level of the included studies using a six-tiered hierarchical
     Add Comment

See-Through Sensors for Better Brain Implants
Spectrum Online - 4 Hours ago
Brain scientists first discovered how to use light to remotely control genetically-modified brain cells about a decade ago — a breakthrough that has enabled new scientific studies of depression, addiction
     Add Comment

Health: High Intensity Interval Training commutes to the cubicle
Business World - 3 Hours ago
NEW YORK -- High Intensity Interval Training, or HIIT, which has successfully sprinted from the playing fields of professional athletes to the fitness centers of everyday exercisers, may be coming to
High Intensity Interval Training Commutes to the Cubicle American Journal of Public Health
High Intensity Interval Training commutes to the cubicle | Reuters DailyMe.Com
all 2 news articles >>      Add Comment

Cost of Stroke Care Does Not Decrease Over Long-Term
General Medicine eJournal - 13 Hours ago
The first study to examine the cost of stroke out to 10 years after the acute event has shown that costs do not diminish in the long term as has previously been suggested. The study, published online
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.